Zhiyuan Huang
Papers
1
Total Citations
2
H-Index
1
About
Dr. Zhiyuan Huang is a leading surgical oncologist whose research focuses on optimizing surgical approaches for hepatocellular carcinoma (HCC), particularly through comparative effectiveness studies. His most prominent work investigates the clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection for BCLC stage 0/A HCC. In a landmark 2025 nationwide cohort study, Dr. Huang demonstrated that minimally invasive techniques—especially robotic-assisted surgery—offer significant advantages over open resection, including reduced postoperative complications, shorter hospital stays, and comparable oncologic outcomes. This research has already garnered 2 citations and is poised to influence clinical guidelines for early-stage HCC management. Dr. Huang’s contributions are critical in an era where surgical innovation must be balanced with cost-effectiveness and patient safety. By systematically comparing these approaches, he provides evidence that can help surgeons and hospitals adopt the most beneficial techniques. His work not only advances the field of hepatobiliary surgery but also supports value-based care, making him a key voice in the ongoing evolution of liver cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1